CJC-1295 & Ipamorelin Synergy
A technical overview of the molecular mechanisms and common laboratory research protocols behind the CJC-1295 + Ipamorelin peptide blend — one of the most widely studied growth hormone secretagogue combinations in preclinical research.
1. Molecular Overview
CJC-1295 is a synthetic 30-amino-acid analog of growth hormone-releasing hormone (GHRH 1-29), modified at four positions (D-Ala², Gln⁸, Ala¹⁵, Leu²⁷) to resist enzymatic degradation by dipeptidyl peptidase-IV (DPP-IV). It acts on the GHRH receptor (GHRH-R) on somatotroph cells in the anterior pituitary, stimulating cAMP-dependent synthesis and pulsatile release of growth hormone (GH).
Ipamorelin is a selective pentapeptide ghrelin receptor (GHS-R1a) agonist. Unlike earlier GHRPs, Ipamorelin does not appreciably elevate cortisol, prolactin, or ACTH at physiologically relevant concentrations in published animal models, making it a valuable tool for isolating the GH axis in laboratory research.
2. Why the Two Are Studied Together
CJC-1295 and Ipamorelin act on two distinct but complementary receptors that both converge on GH release. Preclinical literature describes their combined use as producing a greater, more physiological GH pulse than either peptide alone via three overlapping mechanisms:
- Amplitude: GHRH-R activation increases the amount of GH released per pulse.
- Frequency: GHS-R1a activation via Ipamorelin suppresses somatostatin tone, permitting more frequent pulses.
- Somatotroph priming: Chronic low-dose GHRH signaling upregulates somatotroph population and GH stores, which a ghrelin mimetic can then release.
3. Common Research Protocols
The following reflects protocols described in published preclinical and in-vitro literature. It is provided for informational and academic reference only and is not a use, dosing, or human-administration recommendation.
| Parameter | Typical Range in Literature |
|---|---|
| Reconstitution | Bacteriostatic water, 2–3 mL per 5 mg vial |
| CJC-1295 (no DAC) | 100 mcg equivalent, 1–3× daily |
| Ipamorelin | 100–300 mcg equivalent per pulse |
| Timing | Pre-sleep pulse commonly modeled to align with endogenous GH peak |
| Storage | Lyophilized: 2–8 °C. Reconstituted: refrigerated, protected from light. |
4. Handling & Quality Considerations
- Verify purity (≥ 99%) and identity via third-party HPLC and mass-spectrometry certificates of analysis before use in any assay.
- Avoid repeated freeze–thaw cycles; aliquot reconstituted material.
- Endotoxin-sensitive assays require additional testing beyond a standard identity/purity COA.
Related Products
Vertex Peptides supplies research-grade CJC-1295 and Ipamorelin, individually and as pre-blended vials, each with a third-party COA.